nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CACNA1A—Pregabalin—epilepsy syndrome	0.155	0.501	CbGbCtD
Loperamide—CACNA1A—epilepsy syndrome	0.13	0.387	CbGaD
Loperamide—Doxapram—Fosphenytoin—epilepsy syndrome	0.0944	0.593	CrCrCtD
Loperamide—POMC—epilepsy syndrome	0.0898	0.269	CbGaD
Loperamide—Doxapram—Phenytoin—epilepsy syndrome	0.0647	0.407	CrCrCtD
Loperamide—OPRD1—epilepsy syndrome	0.0506	0.151	CbGaD
Loperamide—OPRM1—epilepsy syndrome	0.0387	0.116	CbGaD
Loperamide—CYP2D6—epilepsy syndrome	0.015	0.0448	CbGaD
Loperamide—ABCB1—epilepsy syndrome	0.0107	0.032	CbGaD
Loperamide—CYP2B6—Fosphenytoin—epilepsy syndrome	0.00828	0.0267	CbGbCtD
Loperamide—CYP2B6—Clobazam—epilepsy syndrome	0.00718	0.0231	CbGbCtD
Loperamide—CYP2C8—Trimethadione—epilepsy syndrome	0.00667	0.0215	CbGbCtD
Loperamide—CYP2C8—Fosphenytoin—epilepsy syndrome	0.00627	0.0202	CbGbCtD
Loperamide—CYP2B6—Carbamazepine—epilepsy syndrome	0.00595	0.0192	CbGbCtD
Loperamide—CYP2B6—Primidone—epilepsy syndrome	0.00556	0.0179	CbGbCtD
Loperamide—CYP2B6—Phenytoin—epilepsy syndrome	0.00534	0.0172	CbGbCtD
Loperamide—ABCB1—Levetiracetam—epilepsy syndrome	0.00531	0.0171	CbGbCtD
Loperamide—CYP2B6—Propofol—epilepsy syndrome	0.00498	0.016	CbGbCtD
Loperamide—POMC—locus ceruleus—epilepsy syndrome	0.00493	0.109	CbGeAlD
Loperamide—CYP2B6—Phenobarbital—epilepsy syndrome	0.00476	0.0153	CbGbCtD
Loperamide—CYP2B6—Midazolam—epilepsy syndrome	0.00469	0.0151	CbGbCtD
Loperamide—CYP2B6—Diazepam—epilepsy syndrome	0.00451	0.0145	CbGbCtD
Loperamide—CYP2C8—Carbamazepine—epilepsy syndrome	0.00451	0.0145	CbGbCtD
Loperamide—CYP2C8—Primidone—epilepsy syndrome	0.00421	0.0136	CbGbCtD
Loperamide—CYP2C8—Phenytoin—epilepsy syndrome	0.00404	0.013	CbGbCtD
Loperamide—CACNA1A—cerebellar cortex—epilepsy syndrome	0.00384	0.0847	CbGeAlD
Loperamide—POMC—vagus nerve—epilepsy syndrome	0.00377	0.0833	CbGeAlD
Loperamide—CYP2C8—Propofol—epilepsy syndrome	0.00377	0.0121	CbGbCtD
Loperamide—ABCB1—Clobazam—epilepsy syndrome	0.00368	0.0119	CbGbCtD
Loperamide—CYP2C8—Phenobarbital—epilepsy syndrome	0.0036	0.0116	CbGbCtD
Loperamide—CYP2B6—Valproic Acid—epilepsy syndrome	0.00355	0.0115	CbGbCtD
Loperamide—ABCB1—Lamotrigine—epilepsy syndrome	0.00354	0.0114	CbGbCtD
Loperamide—CYP2C8—Diazepam—epilepsy syndrome	0.00342	0.011	CbGbCtD
Loperamide—ABCB1—Carbamazepine—epilepsy syndrome	0.00305	0.00983	CbGbCtD
Loperamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00291	0.00938	CbGbCtD
Loperamide—ABCB1—Phenytoin—epilepsy syndrome	0.00274	0.00882	CbGbCtD
Loperamide—CYP3A4—Felbamate—epilepsy syndrome	0.00271	0.00872	CbGbCtD
Loperamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00271	0.00872	CbGbCtD
Loperamide—CYP2C8—Valproic Acid—epilepsy syndrome	0.00269	0.00868	CbGbCtD
Loperamide—POMC—autonomic nervous system—epilepsy syndrome	0.00262	0.0578	CbGeAlD
Loperamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00254	0.0082	CbGbCtD
Loperamide—ABCB1—Phenobarbital—epilepsy syndrome	0.00244	0.00786	CbGbCtD
Loperamide—ABCB1—Midazolam—epilepsy syndrome	0.0024	0.00775	CbGbCtD
Loperamide—CYP2D6—Propofol—epilepsy syndrome	0.0024	0.00775	CbGbCtD
Loperamide—POMC—telencephalic ventricle—epilepsy syndrome	0.00234	0.0516	CbGeAlD
Loperamide—ABCB1—Diazepam—epilepsy syndrome	0.00231	0.00745	CbGbCtD
Loperamide—CYP3A4—Clonazepam—epilepsy syndrome	0.0023	0.00741	CbGbCtD
Loperamide—CYP3A4—Clobazam—epilepsy syndrome	0.00221	0.00711	CbGbCtD
Loperamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00188	0.00604	CbGbCtD
Loperamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00183	0.00589	CbGbCtD
Loperamide—CYP3A4—Primidone—epilepsy syndrome	0.00171	0.0055	CbGbCtD
Loperamide—CYP3A4—Phenytoin—epilepsy syndrome	0.00164	0.00528	CbGbCtD
Loperamide—CYP3A4—Propofol—epilepsy syndrome	0.00153	0.00493	CbGbCtD
Loperamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00146	0.00471	CbGbCtD
Loperamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00146	0.00471	CbGbCtD
Loperamide—POMC—ganglion—epilepsy syndrome	0.00145	0.0321	CbGeAlD
Loperamide—CYP3A4—Midazolam—epilepsy syndrome	0.00144	0.00464	CbGbCtD
Loperamide—CYP3A4—Diazepam—epilepsy syndrome	0.00139	0.00446	CbGbCtD
Loperamide—CYP3A4—Zonisamide—epilepsy syndrome	0.00135	0.00436	CbGbCtD
Loperamide—POMC—hindbrain—epilepsy syndrome	0.0011	0.0244	CbGeAlD
Loperamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.00109	0.00352	CbGbCtD
Loperamide—CACNA1A—hindbrain—epilepsy syndrome	0.00105	0.0233	CbGeAlD
Loperamide—CYP3A4—Topiramate—epilepsy syndrome	0.000985	0.00318	CbGbCtD
Loperamide—OPRM1—telencephalic ventricle—epilepsy syndrome	0.00088	0.0194	CbGeAlD
Loperamide—OPRD1—ganglion—epilepsy syndrome	0.000803	0.0177	CbGeAlD
Loperamide—CALM2—pons—epilepsy syndrome	0.000776	0.0171	CbGeAlD
Loperamide—CALM1—pons—epilepsy syndrome	0.000772	0.017	CbGeAlD
Loperamide—CALM1—autonomic nervous system—epilepsy syndrome	0.000712	0.0157	CbGeAlD
Loperamide—CALM2—ear—epilepsy syndrome	0.000639	0.0141	CbGeAlD
Loperamide—CALM1—ear—epilepsy syndrome	0.000636	0.014	CbGeAlD
Loperamide—POMC—brainstem—epilepsy syndrome	0.000632	0.014	CbGeAlD
Loperamide—POMC—forebrain—epilepsy syndrome	0.00061	0.0135	CbGeAlD
Loperamide—CACNA1A—brainstem—epilepsy syndrome	0.000604	0.0133	CbGeAlD
Loperamide—CACNA1A—forebrain—epilepsy syndrome	0.000583	0.0129	CbGeAlD
Loperamide—POMC—telencephalon—epilepsy syndrome	0.000561	0.0124	CbGeAlD
Loperamide—OPRM1—ganglion—epilepsy syndrome	0.000548	0.0121	CbGeAlD
Loperamide—CACNA1A—telencephalon—epilepsy syndrome	0.000536	0.0118	CbGeAlD
Loperamide—POMC—medulla oblongata—epilepsy syndrome	0.000441	0.00973	CbGeAlD
Loperamide—CACNA1A—medulla oblongata—epilepsy syndrome	0.000421	0.00929	CbGeAlD
Loperamide—POMC—midbrain—epilepsy syndrome	0.000403	0.0089	CbGeAlD
Loperamide—CALM2—ganglion—epilepsy syndrome	0.000397	0.00877	CbGeAlD
Loperamide—CALM1—ganglion—epilepsy syndrome	0.000396	0.00873	CbGeAlD
Loperamide—POMC—spinal cord—epilepsy syndrome	0.000393	0.00868	CbGeAlD
Loperamide—POMC—head—epilepsy syndrome	0.000349	0.00771	CbGeAlD
Loperamide—OPRD1—forebrain—epilepsy syndrome	0.000337	0.00743	CbGeAlD
Loperamide—CACNA1A—head—epilepsy syndrome	0.000334	0.00737	CbGeAlD
Loperamide—POMC—nervous system—epilepsy syndrome	0.000331	0.00731	CbGeAlD
Loperamide—OPRK1—forebrain—epilepsy syndrome	0.000323	0.00713	CbGeAlD
Loperamide—Doxapram—KCNK3—epilepsy syndrome	0.000319	0.111	CrCbGaD
Loperamide—Doxapram—KCNK9—epilepsy syndrome	0.000319	0.111	CrCbGaD
Loperamide—POMC—central nervous system—epilepsy syndrome	0.000319	0.00704	CbGeAlD
Loperamide—CACNA1A—nervous system—epilepsy syndrome	0.000316	0.00698	CbGeAlD
Loperamide—POMC—cerebellum—epilepsy syndrome	0.000312	0.00688	CbGeAlD
Loperamide—OPRD1—telencephalon—epilepsy syndrome	0.00031	0.00684	CbGeAlD
Loperamide—CACNA1A—central nervous system—epilepsy syndrome	0.000305	0.00672	CbGeAlD
Loperamide—CALM2—hindbrain—epilepsy syndrome	0.000301	0.00665	CbGeAlD
Loperamide—CALM1—hindbrain—epilepsy syndrome	0.0003	0.00662	CbGeAlD
Loperamide—CACNA1A—cerebellum—epilepsy syndrome	0.000298	0.00657	CbGeAlD
Loperamide—POMC—brain—epilepsy syndrome	0.000253	0.00559	CbGeAlD
Loperamide—CACNA1A—brain—epilepsy syndrome	0.000242	0.00534	CbGeAlD
Loperamide—OPRM1—brainstem—epilepsy syndrome	0.000238	0.00525	CbGeAlD
Loperamide—OPRM1—forebrain—epilepsy syndrome	0.00023	0.00507	CbGeAlD
Loperamide—OPRM1—telencephalon—epilepsy syndrome	0.000211	0.00466	CbGeAlD
Loperamide—CALM3—telencephalon—epilepsy syndrome	0.000195	0.00431	CbGeAlD
Loperamide—OPRD1—head—epilepsy syndrome	0.000193	0.00426	CbGeAlD
Loperamide—OPRK1—head—epilepsy syndrome	0.000185	0.00408	CbGeAlD
Loperamide—OPRD1—nervous system—epilepsy syndrome	0.000183	0.00404	CbGeAlD
Loperamide—OPRD1—central nervous system—epilepsy syndrome	0.000176	0.00389	CbGeAlD
Loperamide—OPRK1—nervous system—epilepsy syndrome	0.000175	0.00387	CbGeAlD
Loperamide—CALM2—brainstem—epilepsy syndrome	0.000173	0.00381	CbGeAlD
Loperamide—CALM1—brainstem—epilepsy syndrome	0.000172	0.0038	CbGeAlD
Loperamide—OPRK1—central nervous system—epilepsy syndrome	0.000169	0.00373	CbGeAlD
Loperamide—CALM2—forebrain—epilepsy syndrome	0.000167	0.00368	CbGeAlD
Loperamide—CYP2D6—hindbrain—epilepsy syndrome	0.000166	0.00367	CbGeAlD
Loperamide—CALM1—forebrain—epilepsy syndrome	0.000166	0.00366	CbGeAlD
Loperamide—OPRK1—cerebellum—epilepsy syndrome	0.000165	0.00364	CbGeAlD
Loperamide—CALM3—medulla oblongata—epilepsy syndrome	0.000153	0.00339	CbGeAlD
Loperamide—CALM2—telencephalon—epilepsy syndrome	0.000153	0.00338	CbGeAlD
Loperamide—CALM1—telencephalon—epilepsy syndrome	0.000153	0.00337	CbGeAlD
Loperamide—OPRM1—midbrain—epilepsy syndrome	0.000152	0.00335	CbGeAlD
Loperamide—OPRM1—spinal cord—epilepsy syndrome	0.000148	0.00327	CbGeAlD
Loperamide—CALM3—midbrain—epilepsy syndrome	0.00014	0.00309	CbGeAlD
Loperamide—OPRD1—brain—epilepsy syndrome	0.00014	0.00308	CbGeAlD
Loperamide—CALM3—spinal cord—epilepsy syndrome	0.000137	0.00302	CbGeAlD
Loperamide—OPRK1—brain—epilepsy syndrome	0.000134	0.00296	CbGeAlD
Loperamide—OPRM1—head—epilepsy syndrome	0.000132	0.0029	CbGeAlD
Loperamide—OPRM1—nervous system—epilepsy syndrome	0.000125	0.00275	CbGeAlD
Loperamide—CALM2—medulla oblongata—epilepsy syndrome	0.00012	0.00266	CbGeAlD
Loperamide—OPRM1—central nervous system—epilepsy syndrome	0.00012	0.00265	CbGeAlD
Loperamide—CALM1—medulla oblongata—epilepsy syndrome	0.00012	0.00265	CbGeAlD
Loperamide—Difenoxin—OPRM1—epilepsy syndrome	0.000115	0.0401	CrCbGaD
Loperamide—Anileridine—OPRM1—epilepsy syndrome	0.000112	0.0391	CrCbGaD
Loperamide—CALM2—midbrain—epilepsy syndrome	0.00011	0.00243	CbGeAlD
Loperamide—CALM1—midbrain—epilepsy syndrome	0.00011	0.00242	CbGeAlD
Loperamide—CALM3—cerebellum—epilepsy syndrome	0.000108	0.00239	CbGeAlD
Loperamide—CALM2—spinal cord—epilepsy syndrome	0.000107	0.00237	CbGeAlD
Loperamide—CALM1—spinal cord—epilepsy syndrome	0.000107	0.00236	CbGeAlD
Loperamide—Diphenoxylate—OPRD1—epilepsy syndrome	0.000106	0.037	CrCbGaD
Loperamide—CALM2—head—epilepsy syndrome	9.55e-05	0.00211	CbGeAlD
Loperamide—CYP2D6—brainstem—epilepsy syndrome	9.54e-05	0.00211	CbGeAlD
Loperamide—OPRM1—brain—epilepsy syndrome	9.53e-05	0.0021	CbGeAlD
Loperamide—CALM1—head—epilepsy syndrome	9.5e-05	0.0021	CbGeAlD
Loperamide—Methadyl Acetate—OPRM1—epilepsy syndrome	9.38e-05	0.0327	CrCbGaD
Loperamide—CYP2D6—forebrain—epilepsy syndrome	9.21e-05	0.00203	CbGeAlD
Loperamide—CALM2—nervous system—epilepsy syndrome	9.05e-05	0.002	CbGeAlD
Loperamide—CALM1—nervous system—epilepsy syndrome	9.01e-05	0.00199	CbGeAlD
Loperamide—CALM3—brain—epilepsy syndrome	8.81e-05	0.00194	CbGeAlD
Loperamide—Buclizine—CHRM1—epilepsy syndrome	8.8e-05	0.0307	CrCbGaD
Loperamide—CALM2—central nervous system—epilepsy syndrome	8.71e-05	0.00192	CbGeAlD
Loperamide—CALM1—central nervous system—epilepsy syndrome	8.67e-05	0.00191	CbGeAlD
Loperamide—Clidinium—CHRM3—epilepsy syndrome	8.63e-05	0.0301	CrCbGaD
Loperamide—CALM2—cerebellum—epilepsy syndrome	8.52e-05	0.00188	CbGeAlD
Loperamide—CALM1—cerebellum—epilepsy syndrome	8.48e-05	0.00187	CbGeAlD
Loperamide—CYP2D6—telencephalon—epilepsy syndrome	8.47e-05	0.00187	CbGeAlD
Loperamide—Fexofenadine—SLCO1A2—epilepsy syndrome	8.3e-05	0.029	CrCbGaD
Loperamide—Diphenoxylate—OPRM1—epilepsy syndrome	8.1e-05	0.0283	CrCbGaD
Loperamide—Clidinium—CHRM1—epilepsy syndrome	8.05e-05	0.0281	CrCbGaD
Loperamide—Isopropamide—CHRM3—epilepsy syndrome	7.34e-05	0.0256	CrCbGaD
Loperamide—Abdominal pain—Zonisamide—epilepsy syndrome	7.28e-05	0.00101	CcSEcCtD
Loperamide—Hypersensitivity—Vigabatrin—epilepsy syndrome	7.27e-05	0.001	CcSEcCtD
Loperamide—Asthenia—Fosphenytoin—epilepsy syndrome	7.27e-05	0.001	CcSEcCtD
Loperamide—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	7.26e-05	0.001	CcSEcCtD
Loperamide—Gastrointestinal pain—Clonazepam—epilepsy syndrome	7.26e-05	0.001	CcSEcCtD
Loperamide—Fatigue—Carbamazepine—epilepsy syndrome	7.25e-05	0.001	CcSEcCtD
Loperamide—Angioedema—Valproic Acid—epilepsy syndrome	7.23e-05	0.001	CcSEcCtD
Loperamide—Somnolence—Lamotrigine—epilepsy syndrome	7.23e-05	0.000999	CcSEcCtD
Loperamide—Constipation—Carbamazepine—epilepsy syndrome	7.19e-05	0.000994	CcSEcCtD
Loperamide—Dizziness—Propofol—epilepsy syndrome	7.18e-05	0.000992	CcSEcCtD
Loperamide—Diarrhoea—Levetiracetam—epilepsy syndrome	7.18e-05	0.000992	CcSEcCtD
Loperamide—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	7.17e-05	0.000991	CcSEcCtD
Loperamide—Pruritus—Fosphenytoin—epilepsy syndrome	7.17e-05	0.00099	CcSEcCtD
Loperamide—Hypersensitivity—Diazepam—epilepsy syndrome	7.16e-05	0.000989	CcSEcCtD
Loperamide—Dyspepsia—Lamotrigine—epilepsy syndrome	7.16e-05	0.000989	CcSEcCtD
Loperamide—Erythema multiforme—Gabapentin—epilepsy syndrome	7.13e-05	0.000985	CcSEcCtD
Loperamide—CYP2B6—head—epilepsy syndrome	7.1e-05	0.00157	CbGeAlD
Loperamide—Asthenia—Vigabatrin—epilepsy syndrome	7.08e-05	0.000979	CcSEcCtD
Loperamide—Flatulence—Pregabalin—epilepsy syndrome	7.05e-05	0.000975	CcSEcCtD
Loperamide—Urticaria—Clonazepam—epilepsy syndrome	7.05e-05	0.000974	CcSEcCtD
Loperamide—Dizziness—Midazolam—epilepsy syndrome	7.03e-05	0.000971	CcSEcCtD
Loperamide—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	7.02e-05	0.00097	CcSEcCtD
Loperamide—Abdominal pain—Clonazepam—epilepsy syndrome	7.01e-05	0.000969	CcSEcCtD
Loperamide—Fatigue—Lamotrigine—epilepsy syndrome	7.01e-05	0.000969	CcSEcCtD
Loperamide—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	7.01e-05	0.000968	CcSEcCtD
Loperamide—Urticaria—Phenytoin—epilepsy syndrome	7e-05	0.000968	CcSEcCtD
Loperamide—Pruritus—Vigabatrin—epilepsy syndrome	6.98e-05	0.000965	CcSEcCtD
Loperamide—Asthenia—Diazepam—epilepsy syndrome	6.97e-05	0.000963	CcSEcCtD
Loperamide—Urticaria—Oxcarbazepine—epilepsy syndrome	6.97e-05	0.000962	CcSEcCtD
Loperamide—Constipation—Lamotrigine—epilepsy syndrome	6.95e-05	0.000961	CcSEcCtD
Loperamide—Nausea—Acetazolamide—epilepsy syndrome	6.95e-05	0.00096	CcSEcCtD
Loperamide—Mepenzolate—CHRM3—epilepsy syndrome	6.94e-05	0.0242	CrCbGaD
Loperamide—Dizziness—Levetiracetam—epilepsy syndrome	6.94e-05	0.000959	CcSEcCtD
Loperamide—Abdominal pain—Oxcarbazepine—epilepsy syndrome	6.93e-05	0.000958	CcSEcCtD
Loperamide—Diarrhoea—Fosphenytoin—epilepsy syndrome	6.93e-05	0.000957	CcSEcCtD
Loperamide—CALM2—brain—epilepsy syndrome	6.92e-05	0.00153	CbGeAlD
Loperamide—Vomiting—Propofol—epilepsy syndrome	6.91e-05	0.000954	CcSEcCtD
Loperamide—CALM1—brain—epilepsy syndrome	6.89e-05	0.00152	CbGeAlD
Loperamide—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	6.88e-05	0.000951	CcSEcCtD
Loperamide—Pruritus—Diazepam—epilepsy syndrome	6.88e-05	0.00095	CcSEcCtD
Loperamide—Rash—Propofol—epilepsy syndrome	6.85e-05	0.000946	CcSEcCtD
Loperamide—Isopropamide—CHRM1—epilepsy syndrome	6.85e-05	0.0239	CrCbGaD
Loperamide—Dermatitis—Propofol—epilepsy syndrome	6.84e-05	0.000945	CcSEcCtD
Loperamide—Immune system disorder—Gabapentin—epilepsy syndrome	6.81e-05	0.000941	CcSEcCtD
Loperamide—Headache—Propofol—epilepsy syndrome	6.8e-05	0.00094	CcSEcCtD
Loperamide—Hypersensitivity—Zonisamide—epilepsy syndrome	6.78e-05	0.000937	CcSEcCtD
Loperamide—Vomiting—Midazolam—epilepsy syndrome	6.76e-05	0.000934	CcSEcCtD
Loperamide—Diarrhoea—Vigabatrin—epilepsy syndrome	6.75e-05	0.000933	CcSEcCtD
Loperamide—Asthenia—Felbamate—epilepsy syndrome	6.75e-05	0.000932	CcSEcCtD
Loperamide—CYP2B6—nervous system—epilepsy syndrome	6.73e-05	0.00149	CbGeAlD
Loperamide—Rash—Midazolam—epilepsy syndrome	6.7e-05	0.000926	CcSEcCtD
Loperamide—Dizziness—Fosphenytoin—epilepsy syndrome	6.7e-05	0.000925	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	6.69e-05	0.000925	CcSEcCtD
Loperamide—Dermatitis—Midazolam—epilepsy syndrome	6.69e-05	0.000925	CcSEcCtD
Loperamide—Urticaria—Carbamazepine—epilepsy syndrome	6.68e-05	0.000924	CcSEcCtD
Loperamide—Vomiting—Levetiracetam—epilepsy syndrome	6.67e-05	0.000922	CcSEcCtD
Loperamide—Discomfort—Valproic Acid—epilepsy syndrome	6.66e-05	0.00092	CcSEcCtD
Loperamide—Headache—Midazolam—epilepsy syndrome	6.66e-05	0.00092	CcSEcCtD
Loperamide—Pruritus—Felbamate—epilepsy syndrome	6.65e-05	0.00092	CcSEcCtD
Loperamide—Abdominal pain—Carbamazepine—epilepsy syndrome	6.65e-05	0.000919	CcSEcCtD
Loperamide—Diarrhoea—Diazepam—epilepsy syndrome	6.65e-05	0.000919	CcSEcCtD
Loperamide—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	6.65e-05	0.000919	CcSEcCtD
Loperamide—ABCB1—forebrain—epilepsy syndrome	6.62e-05	0.00146	CbGeAlD
Loperamide—Rash—Levetiracetam—epilepsy syndrome	6.62e-05	0.000914	CcSEcCtD
Loperamide—Dermatitis—Levetiracetam—epilepsy syndrome	6.61e-05	0.000913	CcSEcCtD
Loperamide—Asthenia—Zonisamide—epilepsy syndrome	6.61e-05	0.000913	CcSEcCtD
Loperamide—Dry mouth—Valproic Acid—epilepsy syndrome	6.59e-05	0.000911	CcSEcCtD
Loperamide—Headache—Levetiracetam—epilepsy syndrome	6.57e-05	0.000908	CcSEcCtD
Loperamide—Angioedema—Pregabalin—epilepsy syndrome	6.54e-05	0.000904	CcSEcCtD
Loperamide—Hypersensitivity—Clonazepam—epilepsy syndrome	6.54e-05	0.000903	CcSEcCtD
Loperamide—Dizziness—Vigabatrin—epilepsy syndrome	6.53e-05	0.000902	CcSEcCtD
Loperamide—Pruritus—Zonisamide—epilepsy syndrome	6.51e-05	0.0009	CcSEcCtD
Loperamide—Hypersensitivity—Phenytoin—epilepsy syndrome	6.49e-05	0.000897	CcSEcCtD
Loperamide—CYP2B6—central nervous system—epilepsy syndrome	6.48e-05	0.00143	CbGeAlD
Loperamide—Mepenzolate—CHRM1—epilepsy syndrome	6.47e-05	0.0226	CrCbGaD
Loperamide—Flatulence—Gabapentin—epilepsy syndrome	6.47e-05	0.000894	CcSEcCtD
Loperamide—Anaphylactic shock—Valproic Acid—epilepsy syndrome	6.46e-05	0.000893	CcSEcCtD
Loperamide—Urticaria—Lamotrigine—epilepsy syndrome	6.46e-05	0.000893	CcSEcCtD
Loperamide—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	6.46e-05	0.000893	CcSEcCtD
Loperamide—Nausea—Propofol—epilepsy syndrome	6.45e-05	0.000891	CcSEcCtD
Loperamide—Vomiting—Fosphenytoin—epilepsy syndrome	6.44e-05	0.00089	CcSEcCtD
Loperamide—Diarrhoea—Felbamate—epilepsy syndrome	6.44e-05	0.000889	CcSEcCtD
Loperamide—Abdominal pain—Lamotrigine—epilepsy syndrome	6.43e-05	0.000888	CcSEcCtD
Loperamide—Dizziness—Diazepam—epilepsy syndrome	6.43e-05	0.000888	CcSEcCtD
Loperamide—Rash—Fosphenytoin—epilepsy syndrome	6.39e-05	0.000882	CcSEcCtD
Loperamide—Dermatitis—Fosphenytoin—epilepsy syndrome	6.38e-05	0.000881	CcSEcCtD
Loperamide—Asthenia—Clonazepam—epilepsy syndrome	6.37e-05	0.00088	CcSEcCtD
Loperamide—Headache—Fosphenytoin—epilepsy syndrome	6.34e-05	0.000877	CcSEcCtD
Loperamide—Nervous system disorder—Valproic Acid—epilepsy syndrome	6.34e-05	0.000876	CcSEcCtD
Loperamide—Asthenia—Phenytoin—epilepsy syndrome	6.32e-05	0.000874	CcSEcCtD
Loperamide—Nausea—Midazolam—epilepsy syndrome	6.31e-05	0.000872	CcSEcCtD
Loperamide—Diarrhoea—Zonisamide—epilepsy syndrome	6.3e-05	0.00087	CcSEcCtD
Loperamide—Loss of consciousness—Pregabalin—epilepsy syndrome	6.29e-05	0.000869	CcSEcCtD
Loperamide—Asthenia—Oxcarbazepine—epilepsy syndrome	6.29e-05	0.000869	CcSEcCtD
Loperamide—Pruritus—Clonazepam—epilepsy syndrome	6.28e-05	0.000867	CcSEcCtD
Loperamide—Vomiting—Vigabatrin—epilepsy syndrome	6.28e-05	0.000867	CcSEcCtD
Loperamide—Skin disorder—Valproic Acid—epilepsy syndrome	6.28e-05	0.000867	CcSEcCtD
Loperamide—Urinary tract disorder—Topiramate—epilepsy syndrome	6.26e-05	0.000866	CcSEcCtD
Loperamide—Pruritus—Phenytoin—epilepsy syndrome	6.24e-05	0.000862	CcSEcCtD
Loperamide—Nausea—Levetiracetam—epilepsy syndrome	6.23e-05	0.000861	CcSEcCtD
Loperamide—Rash—Vigabatrin—epilepsy syndrome	6.22e-05	0.00086	CcSEcCtD
Loperamide—Dizziness—Felbamate—epilepsy syndrome	6.22e-05	0.000859	CcSEcCtD
Loperamide—Dermatitis—Vigabatrin—epilepsy syndrome	6.22e-05	0.000859	CcSEcCtD
Loperamide—Urethral disorder—Topiramate—epilepsy syndrome	6.22e-05	0.000859	CcSEcCtD
Loperamide—Pruritus—Oxcarbazepine—epilepsy syndrome	6.2e-05	0.000857	CcSEcCtD
Loperamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.2e-05	0.000856	CcSEcCtD
Loperamide—Headache—Vigabatrin—epilepsy syndrome	6.18e-05	0.000854	CcSEcCtD
Loperamide—Vomiting—Diazepam—epilepsy syndrome	6.18e-05	0.000854	CcSEcCtD
Loperamide—Rash—Diazepam—epilepsy syndrome	6.13e-05	0.000847	CcSEcCtD
Loperamide—Dermatitis—Diazepam—epilepsy syndrome	6.12e-05	0.000846	CcSEcCtD
Loperamide—ABCB1—telencephalon—epilepsy syndrome	6.09e-05	0.00134	CbGeAlD
Loperamide—Dizziness—Zonisamide—epilepsy syndrome	6.09e-05	0.000841	CcSEcCtD
Loperamide—Headache—Diazepam—epilepsy syndrome	6.09e-05	0.000841	CcSEcCtD
Loperamide—Diphenidol—CHRM3—epilepsy syndrome	6.08e-05	0.0212	CrCbGaD
Loperamide—Diarrhoea—Clonazepam—epilepsy syndrome	6.07e-05	0.000839	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.05e-05	0.000836	CcSEcCtD
Loperamide—Asthenia—Carbamazepine—epilepsy syndrome	6.04e-05	0.000834	CcSEcCtD
Loperamide—Darifenacin—CHRM3—epilepsy syndrome	6.03e-05	0.0211	CrCbGaD
Loperamide—Diarrhoea—Phenytoin—epilepsy syndrome	6.03e-05	0.000833	CcSEcCtD
Loperamide—Discomfort—Pregabalin—epilepsy syndrome	6.02e-05	0.000832	CcSEcCtD
Loperamide—Nausea—Fosphenytoin—epilepsy syndrome	6.02e-05	0.000831	CcSEcCtD
Loperamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6e-05	0.000829	CcSEcCtD
Loperamide—Erythema multiforme—Topiramate—epilepsy syndrome	6e-05	0.000829	CcSEcCtD
Loperamide—Angioedema—Gabapentin—epilepsy syndrome	6e-05	0.000829	CcSEcCtD
Loperamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.99e-05	0.000828	CcSEcCtD
Loperamide—Vomiting—Felbamate—epilepsy syndrome	5.98e-05	0.000826	CcSEcCtD
Loperamide—Dry mouth—Pregabalin—epilepsy syndrome	5.96e-05	0.000823	CcSEcCtD
Loperamide—Pruritus—Carbamazepine—epilepsy syndrome	5.95e-05	0.000822	CcSEcCtD
Loperamide—Rash—Felbamate—epilepsy syndrome	5.93e-05	0.000819	CcSEcCtD
Loperamide—Dermatitis—Felbamate—epilepsy syndrome	5.93e-05	0.000819	CcSEcCtD
Loperamide—Headache—Felbamate—epilepsy syndrome	5.89e-05	0.000814	CcSEcCtD
Loperamide—Dizziness—Clonazepam—epilepsy syndrome	5.87e-05	0.000811	CcSEcCtD
Loperamide—Nausea—Vigabatrin—epilepsy syndrome	5.86e-05	0.00081	CcSEcCtD
Loperamide—Vomiting—Zonisamide—epilepsy syndrome	5.85e-05	0.000809	CcSEcCtD
Loperamide—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.84e-05	0.000807	CcSEcCtD
Loperamide—Asthenia—Lamotrigine—epilepsy syndrome	5.83e-05	0.000806	CcSEcCtD
Loperamide—Dizziness—Phenytoin—epilepsy syndrome	5.83e-05	0.000805	CcSEcCtD
Loperamide—Rash—Zonisamide—epilepsy syndrome	5.81e-05	0.000802	CcSEcCtD
Loperamide—Dermatitis—Zonisamide—epilepsy syndrome	5.8e-05	0.000801	CcSEcCtD
Loperamide—Dizziness—Oxcarbazepine—epilepsy syndrome	5.8e-05	0.000801	CcSEcCtD
Loperamide—Nausea—Diazepam—epilepsy syndrome	5.77e-05	0.000798	CcSEcCtD
Loperamide—Loss of consciousness—Gabapentin—epilepsy syndrome	5.77e-05	0.000797	CcSEcCtD
Loperamide—Headache—Zonisamide—epilepsy syndrome	5.77e-05	0.000797	CcSEcCtD
Loperamide—Diarrhoea—Carbamazepine—epilepsy syndrome	5.76e-05	0.000795	CcSEcCtD
Loperamide—Pruritus—Lamotrigine—epilepsy syndrome	5.75e-05	0.000795	CcSEcCtD
Loperamide—Somnolence—Valproic Acid—epilepsy syndrome	5.74e-05	0.000794	CcSEcCtD
Loperamide—CYP2C8—brain—epilepsy syndrome	5.73e-05	0.00127	CbGeAlD
Loperamide—Haloperidol—GRIN2B—epilepsy syndrome	5.73e-05	0.02	CrCbGaD
Loperamide—Immune system disorder—Topiramate—epilepsy syndrome	5.73e-05	0.000792	CcSEcCtD
Loperamide—Nervous system disorder—Pregabalin—epilepsy syndrome	5.73e-05	0.000792	CcSEcCtD
Loperamide—Dyspepsia—Valproic Acid—epilepsy syndrome	5.69e-05	0.000786	CcSEcCtD
Loperamide—Skin disorder—Pregabalin—epilepsy syndrome	5.67e-05	0.000784	CcSEcCtD
Loperamide—Diphenidol—CHRM1—epilepsy syndrome	5.67e-05	0.0198	CrCbGaD
Loperamide—Vomiting—Clonazepam—epilepsy syndrome	5.64e-05	0.00078	CcSEcCtD
Loperamide—Darifenacin—CHRM1—epilepsy syndrome	5.63e-05	0.0196	CrCbGaD
Loperamide—Vomiting—Phenytoin—epilepsy syndrome	5.6e-05	0.000774	CcSEcCtD
Loperamide—Rash—Clonazepam—epilepsy syndrome	5.59e-05	0.000773	CcSEcCtD
Loperamide—Dermatitis—Clonazepam—epilepsy syndrome	5.59e-05	0.000772	CcSEcCtD
Loperamide—Nausea—Felbamate—epilepsy syndrome	5.59e-05	0.000772	CcSEcCtD
Loperamide—Clotrimazole—CYP11A1—epilepsy syndrome	5.58e-05	0.0195	CrCbGaD
Loperamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.58e-05	0.000771	CcSEcCtD
Loperamide—Vomiting—Oxcarbazepine—epilepsy syndrome	5.57e-05	0.00077	CcSEcCtD
Loperamide—Fatigue—Valproic Acid—epilepsy syndrome	5.57e-05	0.00077	CcSEcCtD
Loperamide—Dizziness—Carbamazepine—epilepsy syndrome	5.56e-05	0.000769	CcSEcCtD
Loperamide—Diarrhoea—Lamotrigine—epilepsy syndrome	5.56e-05	0.000769	CcSEcCtD
Loperamide—Headache—Clonazepam—epilepsy syndrome	5.56e-05	0.000768	CcSEcCtD
Loperamide—Rash—Phenytoin—epilepsy syndrome	5.56e-05	0.000768	CcSEcCtD
Loperamide—Dermatitis—Phenytoin—epilepsy syndrome	5.55e-05	0.000767	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.55e-05	0.000767	CcSEcCtD
Loperamide—Rash—Oxcarbazepine—epilepsy syndrome	5.53e-05	0.000764	CcSEcCtD
Loperamide—Constipation—Valproic Acid—epilepsy syndrome	5.53e-05	0.000763	CcSEcCtD
Loperamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.52e-05	0.000763	CcSEcCtD
Loperamide—Headache—Phenytoin—epilepsy syndrome	5.52e-05	0.000763	CcSEcCtD
Loperamide—Discomfort—Gabapentin—epilepsy syndrome	5.52e-05	0.000763	CcSEcCtD
Loperamide—Headache—Oxcarbazepine—epilepsy syndrome	5.49e-05	0.000759	CcSEcCtD
Loperamide—Nausea—Zonisamide—epilepsy syndrome	5.47e-05	0.000756	CcSEcCtD
Loperamide—Dry mouth—Gabapentin—epilepsy syndrome	5.46e-05	0.000755	CcSEcCtD
Loperamide—Flatulence—Topiramate—epilepsy syndrome	5.44e-05	0.000752	CcSEcCtD
Loperamide—Dizziness—Lamotrigine—epilepsy syndrome	5.38e-05	0.000743	CcSEcCtD
Loperamide—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.36e-05	0.00074	CcSEcCtD
Loperamide—Vomiting—Carbamazepine—epilepsy syndrome	5.35e-05	0.000739	CcSEcCtD
Loperamide—Rash—Carbamazepine—epilepsy syndrome	5.3e-05	0.000733	CcSEcCtD
Loperamide—Dermatitis—Carbamazepine—epilepsy syndrome	5.3e-05	0.000732	CcSEcCtD
Loperamide—Mepenzolate—CHRM2—epilepsy syndrome	5.29e-05	0.0184	CrCbGaD
Loperamide—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.28e-05	0.00073	CcSEcCtD
Loperamide—CYP2D6—head—epilepsy syndrome	5.27e-05	0.00116	CbGeAlD
Loperamide—Nausea—Clonazepam—epilepsy syndrome	5.27e-05	0.000728	CcSEcCtD
Loperamide—Headache—Carbamazepine—epilepsy syndrome	5.27e-05	0.000728	CcSEcCtD
Loperamide—Nervous system disorder—Gabapentin—epilepsy syndrome	5.25e-05	0.000726	CcSEcCtD
Loperamide—Nausea—Phenytoin—epilepsy syndrome	5.24e-05	0.000723	CcSEcCtD
Loperamide—Nausea—Oxcarbazepine—epilepsy syndrome	5.21e-05	0.00072	CcSEcCtD
Loperamide—Skin disorder—Gabapentin—epilepsy syndrome	5.2e-05	0.000719	CcSEcCtD
Loperamide—Somnolence—Pregabalin—epilepsy syndrome	5.19e-05	0.000718	CcSEcCtD
Loperamide—Vomiting—Lamotrigine—epilepsy syndrome	5.17e-05	0.000714	CcSEcCtD
Loperamide—CYP2B6—brain—epilepsy syndrome	5.14e-05	0.00114	CbGeAlD
Loperamide—Urticaria—Valproic Acid—epilepsy syndrome	5.13e-05	0.000709	CcSEcCtD
Loperamide—Rash—Lamotrigine—epilepsy syndrome	5.13e-05	0.000708	CcSEcCtD
Loperamide—Dermatitis—Lamotrigine—epilepsy syndrome	5.12e-05	0.000708	CcSEcCtD
Loperamide—Abdominal pain—Valproic Acid—epilepsy syndrome	5.11e-05	0.000706	CcSEcCtD
Loperamide—Headache—Lamotrigine—epilepsy syndrome	5.09e-05	0.000704	CcSEcCtD
Loperamide—CYP3A4—nervous system—epilepsy syndrome	5.08e-05	0.00112	CbGeAlD
Loperamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.04e-05	0.000697	CcSEcCtD
Loperamide—Fatigue—Pregabalin—epilepsy syndrome	5.04e-05	0.000696	CcSEcCtD
Loperamide—CYP2D6—nervous system—epilepsy syndrome	5e-05	0.0011	CbGeAlD
Loperamide—Nausea—Carbamazepine—epilepsy syndrome	5e-05	0.000691	CcSEcCtD
Loperamide—Constipation—Pregabalin—epilepsy syndrome	5e-05	0.00069	CcSEcCtD
Loperamide—CYP3A4—central nervous system—epilepsy syndrome	4.89e-05	0.00108	CbGeAlD
Loperamide—Loss of consciousness—Topiramate—epilepsy syndrome	4.85e-05	0.000671	CcSEcCtD
Loperamide—Nausea—Lamotrigine—epilepsy syndrome	4.83e-05	0.000667	CcSEcCtD
Loperamide—CYP2D6—central nervous system—epilepsy syndrome	4.81e-05	0.00106	CbGeAlD
Loperamide—ABCB1—medulla oblongata—epilepsy syndrome	4.79e-05	0.00106	CbGeAlD
Loperamide—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.78e-05	0.00066	CcSEcCtD
Loperamide—Somnolence—Gabapentin—epilepsy syndrome	4.76e-05	0.000658	CcSEcCtD
Loperamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.76e-05	0.000658	CcSEcCtD
Loperamide—Dyspepsia—Gabapentin—epilepsy syndrome	4.72e-05	0.000652	CcSEcCtD
Loperamide—CYP2D6—cerebellum—epilepsy syndrome	4.7e-05	0.00104	CbGeAlD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.67e-05	0.000645	CcSEcCtD
Loperamide—Discomfort—Topiramate—epilepsy syndrome	4.64e-05	0.000642	CcSEcCtD
Loperamide—Urticaria—Pregabalin—epilepsy syndrome	4.64e-05	0.000641	CcSEcCtD
Loperamide—Asthenia—Valproic Acid—epilepsy syndrome	4.64e-05	0.000641	CcSEcCtD
Loperamide—Diphenidol—CHRM2—epilepsy syndrome	4.63e-05	0.0162	CrCbGaD
Loperamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.62e-05	0.000639	CcSEcCtD
Loperamide—Fatigue—Gabapentin—epilepsy syndrome	4.62e-05	0.000638	CcSEcCtD
Loperamide—Abdominal pain—Pregabalin—epilepsy syndrome	4.62e-05	0.000638	CcSEcCtD
Loperamide—Dextropropoxyphene—OPRD1—epilepsy syndrome	4.61e-05	0.0161	CrCbGaD
Loperamide—Dry mouth—Topiramate—epilepsy syndrome	4.6e-05	0.000635	CcSEcCtD
Loperamide—Darifenacin—CHRM2—epilepsy syndrome	4.59e-05	0.016	CrCbGaD
Loperamide—Constipation—Gabapentin—epilepsy syndrome	4.58e-05	0.000633	CcSEcCtD
Loperamide—Pruritus—Valproic Acid—epilepsy syndrome	4.57e-05	0.000632	CcSEcCtD
Loperamide—Fentanyl—OPRD1—epilepsy syndrome	4.56e-05	0.0159	CrCbGaD
Loperamide—Diarrhoea—Valproic Acid—epilepsy syndrome	4.42e-05	0.000611	CcSEcCtD
Loperamide—Nervous system disorder—Topiramate—epilepsy syndrome	4.42e-05	0.000611	CcSEcCtD
Loperamide—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.38e-05	0.000605	CcSEcCtD
Loperamide—Skin disorder—Topiramate—epilepsy syndrome	4.38e-05	0.000605	CcSEcCtD
Loperamide—ABCB1—midbrain—epilepsy syndrome	4.37e-05	0.000966	CbGeAlD
Loperamide—Hypersensitivity—Pregabalin—epilepsy syndrome	4.3e-05	0.000595	CcSEcCtD
Loperamide—Dizziness—Valproic Acid—epilepsy syndrome	4.27e-05	0.00059	CcSEcCtD
Loperamide—ABCB1—spinal cord—epilepsy syndrome	4.27e-05	0.000942	CbGeAlD
Loperamide—Urticaria—Gabapentin—epilepsy syndrome	4.26e-05	0.000588	CcSEcCtD
Loperamide—Abdominal pain—Gabapentin—epilepsy syndrome	4.23e-05	0.000585	CcSEcCtD
Loperamide—Asthenia—Pregabalin—epilepsy syndrome	4.19e-05	0.000579	CcSEcCtD
Loperamide—Pruritus—Pregabalin—epilepsy syndrome	4.13e-05	0.000571	CcSEcCtD
Loperamide—Vomiting—Valproic Acid—epilepsy syndrome	4.11e-05	0.000568	CcSEcCtD
Loperamide—Levomethadyl Acetate—OPRM1—epilepsy syndrome	4.08e-05	0.0142	CrCbGaD
Loperamide—Rash—Valproic Acid—epilepsy syndrome	4.07e-05	0.000563	CcSEcCtD
Loperamide—Dermatitis—Valproic Acid—epilepsy syndrome	4.07e-05	0.000562	CcSEcCtD
Loperamide—Headache—Valproic Acid—epilepsy syndrome	4.05e-05	0.000559	CcSEcCtD
Loperamide—Somnolence—Topiramate—epilepsy syndrome	4.01e-05	0.000554	CcSEcCtD
Loperamide—Diarrhoea—Pregabalin—epilepsy syndrome	4e-05	0.000552	CcSEcCtD
Loperamide—Dyspepsia—Topiramate—epilepsy syndrome	3.97e-05	0.000548	CcSEcCtD
Loperamide—Hypersensitivity—Gabapentin—epilepsy syndrome	3.95e-05	0.000545	CcSEcCtD
Loperamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.89e-05	0.000538	CcSEcCtD
Loperamide—Fatigue—Topiramate—epilepsy syndrome	3.89e-05	0.000537	CcSEcCtD
Loperamide—Dizziness—Pregabalin—epilepsy syndrome	3.86e-05	0.000534	CcSEcCtD
Loperamide—Constipation—Topiramate—epilepsy syndrome	3.85e-05	0.000532	CcSEcCtD
Loperamide—Asthenia—Gabapentin—epilepsy syndrome	3.84e-05	0.000531	CcSEcCtD
Loperamide—Nausea—Valproic Acid—epilepsy syndrome	3.84e-05	0.00053	CcSEcCtD
Loperamide—CYP2D6—brain—epilepsy syndrome	3.82e-05	0.000844	CbGeAlD
Loperamide—ABCB1—head—epilepsy syndrome	3.79e-05	0.000837	CbGeAlD
Loperamide—Pruritus—Gabapentin—epilepsy syndrome	3.79e-05	0.000524	CcSEcCtD
Loperamide—Vomiting—Pregabalin—epilepsy syndrome	3.71e-05	0.000513	CcSEcCtD
Loperamide—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.69e-05	0.000509	CcSEcCtD
Loperamide—Rash—Pregabalin—epilepsy syndrome	3.68e-05	0.000509	CcSEcCtD
Loperamide—Dermatitis—Pregabalin—epilepsy syndrome	3.68e-05	0.000508	CcSEcCtD
Loperamide—Diarrhoea—Gabapentin—epilepsy syndrome	3.66e-05	0.000506	CcSEcCtD
Loperamide—Headache—Pregabalin—epilepsy syndrome	3.66e-05	0.000506	CcSEcCtD
Loperamide—ABCB1—nervous system—epilepsy syndrome	3.6e-05	0.000794	CbGeAlD
Loperamide—Urticaria—Topiramate—epilepsy syndrome	3.58e-05	0.000495	CcSEcCtD
Loperamide—Abdominal pain—Topiramate—epilepsy syndrome	3.56e-05	0.000492	CcSEcCtD
Loperamide—Dizziness—Gabapentin—epilepsy syndrome	3.54e-05	0.000489	CcSEcCtD
Loperamide—Dextropropoxyphene—OPRM1—epilepsy syndrome	3.53e-05	0.0123	CrCbGaD
Loperamide—Fentanyl—OPRM1—epilepsy syndrome	3.49e-05	0.0122	CrCbGaD
Loperamide—Nausea—Pregabalin—epilepsy syndrome	3.47e-05	0.000479	CcSEcCtD
Loperamide—ABCB1—central nervous system—epilepsy syndrome	3.46e-05	0.000764	CbGeAlD
Loperamide—Vomiting—Gabapentin—epilepsy syndrome	3.41e-05	0.000471	CcSEcCtD
Loperamide—ABCB1—cerebellum—epilepsy syndrome	3.38e-05	0.000747	CbGeAlD
Loperamide—Rash—Gabapentin—epilepsy syndrome	3.38e-05	0.000467	CcSEcCtD
Loperamide—Dermatitis—Gabapentin—epilepsy syndrome	3.37e-05	0.000466	CcSEcCtD
Loperamide—Headache—Gabapentin—epilepsy syndrome	3.36e-05	0.000464	CcSEcCtD
Loperamide—Hypersensitivity—Topiramate—epilepsy syndrome	3.32e-05	0.000459	CcSEcCtD
Loperamide—Asthenia—Topiramate—epilepsy syndrome	3.23e-05	0.000447	CcSEcCtD
Loperamide—Pruritus—Topiramate—epilepsy syndrome	3.19e-05	0.000441	CcSEcCtD
Loperamide—Nausea—Gabapentin—epilepsy syndrome	3.18e-05	0.00044	CcSEcCtD
Loperamide—Methadone—OPRD1—epilepsy syndrome	3.13e-05	0.0109	CrCbGaD
Loperamide—Diarrhoea—Topiramate—epilepsy syndrome	3.08e-05	0.000426	CcSEcCtD
Loperamide—Clotrimazole—ABCC2—epilepsy syndrome	3.07e-05	0.0107	CrCbGaD
Loperamide—Dizziness—Topiramate—epilepsy syndrome	2.98e-05	0.000412	CcSEcCtD
Loperamide—Clemastine—CYP2D6—epilepsy syndrome	2.95e-05	0.0103	CrCbGaD
Loperamide—Vomiting—Topiramate—epilepsy syndrome	2.87e-05	0.000396	CcSEcCtD
Loperamide—Rash—Topiramate—epilepsy syndrome	2.84e-05	0.000393	CcSEcCtD
Loperamide—Dermatitis—Topiramate—epilepsy syndrome	2.84e-05	0.000392	CcSEcCtD
Loperamide—Headache—Topiramate—epilepsy syndrome	2.82e-05	0.00039	CcSEcCtD
Loperamide—ABCB1—brain—epilepsy syndrome	2.75e-05	0.000607	CbGeAlD
Loperamide—Nausea—Topiramate—epilepsy syndrome	2.68e-05	0.00037	CcSEcCtD
Loperamide—Methadone—OPRM1—epilepsy syndrome	2.39e-05	0.00835	CrCbGaD
Loperamide—Clotrimazole—CYP2C19—epilepsy syndrome	2.13e-05	0.00744	CrCbGaD
Loperamide—Darifenacin—CYP2D6—epilepsy syndrome	2.1e-05	0.00734	CrCbGaD
Loperamide—Fexofenadine—CYP2D6—epilepsy syndrome	2.04e-05	0.00714	CrCbGaD
Loperamide—Haloperidol—CYP2C19—epilepsy syndrome	1.92e-05	0.0067	CrCbGaD
Loperamide—Tamoxifen—ABCC2—epilepsy syndrome	1.81e-05	0.00633	CrCbGaD
Loperamide—Toremifene—ABCB1—epilepsy syndrome	1.67e-05	0.00583	CrCbGaD
Loperamide—Tamoxifen—ABCG2—epilepsy syndrome	1.6e-05	0.00559	CrCbGaD
Loperamide—Clotrimazole—CYP2D6—epilepsy syndrome	1.58e-05	0.00552	CrCbGaD
Loperamide—Haloperidol—HTR2A—epilepsy syndrome	1.56e-05	0.00543	CrCbGaD
Loperamide—Fexofenadine—ABCB1—epilepsy syndrome	1.46e-05	0.0051	CrCbGaD
Loperamide—Haloperidol—CYP2D6—epilepsy syndrome	1.42e-05	0.00497	CrCbGaD
Loperamide—Dextropropoxyphene—CYP2D6—epilepsy syndrome	1.37e-05	0.00477	CrCbGaD
Loperamide—Tamoxifen—CYP2C19—epilepsy syndrome	1.26e-05	0.0044	CrCbGaD
Loperamide—Methadone—CYP2C19—epilepsy syndrome	1.25e-05	0.00436	CrCbGaD
Loperamide—Clotrimazole—ABCB1—epilepsy syndrome	1.13e-05	0.00394	CrCbGaD
Loperamide—Haloperidol—ABCB1—epilepsy syndrome	1.02e-05	0.00355	CrCbGaD
Loperamide—Fentanyl—ABCB1—epilepsy syndrome	9.65e-06	0.00337	CrCbGaD
Loperamide—Tamoxifen—CYP2D6—epilepsy syndrome	9.34e-06	0.00326	CrCbGaD
Loperamide—Methadone—CYP2D6—epilepsy syndrome	9.26e-06	0.00323	CrCbGaD
Loperamide—Tamoxifen—ABCB1—epilepsy syndrome	6.67e-06	0.00233	CrCbGaD
Loperamide—Methadone—ABCB1—epilepsy syndrome	6.62e-06	0.00231	CrCbGaD
Loperamide—OPRD1—Signaling Pathways—JUN—epilepsy syndrome	9.27e-07	1.22e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—GPX1—epilepsy syndrome	9.27e-07	1.22e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—GPX1—epilepsy syndrome	9.27e-07	1.22e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6ST—epilepsy syndrome	9.23e-07	1.22e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	9.22e-07	1.22e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CAT—epilepsy syndrome	9.22e-07	1.22e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SOCS3—epilepsy syndrome	9.21e-07	1.22e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CDC42—epilepsy syndrome	9.19e-07	1.21e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—TH—epilepsy syndrome	9.19e-07	1.21e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—FOS—epilepsy syndrome	9.16e-07	1.21e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—NOS2—epilepsy syndrome	9.16e-07	1.21e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MTOR—epilepsy syndrome	9.1e-07	1.2e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—epilepsy syndrome	9.02e-07	1.19e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—S100B—epilepsy syndrome	9e-07	1.19e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—S100B—epilepsy syndrome	9e-07	1.19e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	8.97e-07	1.18e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CASP8—epilepsy syndrome	8.95e-07	1.18e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6ST—epilepsy syndrome	8.93e-07	1.18e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6ST—epilepsy syndrome	8.93e-07	1.18e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SOCS3—epilepsy syndrome	8.91e-07	1.18e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SOCS3—epilepsy syndrome	8.91e-07	1.18e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AVP—epilepsy syndrome	8.9e-07	1.17e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CDC42—epilepsy syndrome	8.89e-07	1.17e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CDC42—epilepsy syndrome	8.89e-07	1.17e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—FOS—epilepsy syndrome	8.86e-07	1.17e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—FOS—epilepsy syndrome	8.86e-07	1.17e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—NOS2—epilepsy syndrome	8.86e-07	1.17e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—NOS2—epilepsy syndrome	8.86e-07	1.17e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—AKT1—epilepsy syndrome	8.75e-07	1.15e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CASP8—epilepsy syndrome	8.66e-07	1.14e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CASP8—epilepsy syndrome	8.66e-07	1.14e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AGT—epilepsy syndrome	8.63e-07	1.14e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AVP—epilepsy syndrome	8.61e-07	1.14e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AVP—epilepsy syndrome	8.61e-07	1.14e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—APOE—epilepsy syndrome	8.46e-07	1.12e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—FGF2—epilepsy syndrome	8.45e-07	1.11e-05	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—AKT1—epilepsy syndrome	8.45e-07	1.11e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HES1—epilepsy syndrome	8.41e-07	1.11e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AGT—epilepsy syndrome	8.4e-07	1.11e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CASP3—epilepsy syndrome	8.37e-07	1.1e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—GPX1—epilepsy syndrome	8.34e-07	1.1e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—SRC—epilepsy syndrome	8.32e-07	1.1e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—APOE—epilepsy syndrome	8.23e-07	1.09e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FYN—epilepsy syndrome	8.18e-07	1.08e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—H2AFX—epilepsy syndrome	8.15e-07	1.08e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HES1—epilepsy syndrome	8.14e-07	1.07e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HES1—epilepsy syndrome	8.14e-07	1.07e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MEF2C—epilepsy syndrome	8.14e-07	1.07e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—HMOX1—epilepsy syndrome	8.14e-07	1.07e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—JUN—epilepsy syndrome	8.13e-07	1.07e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AGT—epilepsy syndrome	8.13e-07	1.07e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AGT—epilepsy syndrome	8.13e-07	1.07e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—VEGFA—epilepsy syndrome	8.1e-07	1.07e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—FGF2—epilepsy syndrome	8.09e-07	1.07e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CAT—epilepsy syndrome	8.03e-07	1.06e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—APOE—epilepsy syndrome	7.96e-07	1.05e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—APOE—epilepsy syndrome	7.96e-07	1.05e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FYN—epilepsy syndrome	7.92e-07	1.04e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FYN—epilepsy syndrome	7.92e-07	1.04e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—epilepsy syndrome	7.91e-07	1.04e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—H2AFX—epilepsy syndrome	7.89e-07	1.04e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—H2AFX—epilepsy syndrome	7.89e-07	1.04e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MEF2C—epilepsy syndrome	7.87e-07	1.04e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MEF2C—epilepsy syndrome	7.87e-07	1.04e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—YWHAZ—epilepsy syndrome	7.87e-07	1.04e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—RELA—epilepsy syndrome	7.84e-07	1.03e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—FGF2—epilepsy syndrome	7.82e-07	1.03e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—FGF2—epilepsy syndrome	7.82e-07	1.03e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NGF—epilepsy syndrome	7.78e-07	1.03e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.71e-07	1.02e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MTOR—epilepsy syndrome	7.69e-07	1.01e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—BCL2—epilepsy syndrome	7.68e-07	1.01e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—AKT1—epilepsy syndrome	7.67e-07	1.01e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	7.67e-07	1.01e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—YWHAZ—epilepsy syndrome	7.61e-07	1e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.61e-07	1e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CAT—epilepsy syndrome	7.57e-07	9.98e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCR5—epilepsy syndrome	7.57e-07	9.98e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NGF—epilepsy syndrome	7.52e-07	9.92e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NGF—epilepsy syndrome	7.52e-07	9.92e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.51e-07	9.91e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—RELA—epilepsy syndrome	7.51e-07	9.9e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.47e-07	9.85e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—FGF2—epilepsy syndrome	7.47e-07	9.85e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—BCL2—epilepsy syndrome	7.43e-07	9.8e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—BCL2—epilepsy syndrome	7.43e-07	9.8e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR2A—epilepsy syndrome	7.4e-07	9.76e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—MTOR—epilepsy syndrome	7.36e-07	9.71e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	7.36e-07	9.71e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCR5—epilepsy syndrome	7.32e-07	9.65e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCR5—epilepsy syndrome	7.32e-07	9.65e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AGT—epilepsy syndrome	7.31e-07	9.64e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—SRC—epilepsy syndrome	7.29e-07	9.62e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—POMC—epilepsy syndrome	7.27e-07	9.58e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—RELA—epilepsy syndrome	7.26e-07	9.58e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—RELA—epilepsy syndrome	7.26e-07	9.58e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—GPX1—epilepsy syndrome	7.26e-07	9.58e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—FGF2—epilepsy syndrome	7.22e-07	9.53e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—FGF2—epilepsy syndrome	7.22e-07	9.53e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR2A—epilepsy syndrome	7.16e-07	9.45e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR2A—epilepsy syndrome	7.16e-07	9.45e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—APOE—epilepsy syndrome	7.16e-07	9.44e-06	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.14e-07	9.41e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—MTOR—epilepsy syndrome	7.12e-07	9.39e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—MTOR—epilepsy syndrome	7.12e-07	9.39e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—VEGFA—epilepsy syndrome	7.1e-07	9.37e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CASP3—epilepsy syndrome	7.07e-07	9.33e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—POMC—epilepsy syndrome	7.07e-07	9.33e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TSC2—epilepsy syndrome	7.03e-07	9.28e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AGT—epilepsy syndrome	7.03e-07	9.27e-06	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—AKT1—epilepsy syndrome	6.99e-07	9.22e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—APOE—epilepsy syndrome	6.88e-07	9.08e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—JUN—epilepsy syndrome	6.87e-07	9.06e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—GPX1—epilepsy syndrome	6.84e-07	9.02e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—POMC—epilepsy syndrome	6.84e-07	9.02e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—POMC—epilepsy syndrome	6.84e-07	9.02e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TSC2—epilepsy syndrome	6.8e-07	8.97e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TSC2—epilepsy syndrome	6.8e-07	8.97e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—MTOR—epilepsy syndrome	6.8e-07	8.96e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AGT—epilepsy syndrome	6.8e-07	8.96e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AGT—epilepsy syndrome	6.8e-07	8.96e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—epilepsy syndrome	6.79e-07	8.95e-06	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—AKT1—epilepsy syndrome	6.76e-07	8.92e-06	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—AKT1—epilepsy syndrome	6.76e-07	8.92e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—KDR—epilepsy syndrome	6.74e-07	8.89e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.74e-07	8.89e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—epilepsy syndrome	6.74e-07	8.88e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—epilepsy syndrome	6.68e-07	8.81e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—APOE—epilepsy syndrome	6.66e-07	8.78e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—APOE—epilepsy syndrome	6.66e-07	8.78e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ALB—epilepsy syndrome	6.62e-07	8.74e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—JUN—epilepsy syndrome	6.58e-07	8.67e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—MTOR—epilepsy syndrome	6.58e-07	8.67e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—MTOR—epilepsy syndrome	6.58e-07	8.67e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—epilepsy syndrome	6.57e-07	8.66e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—epilepsy syndrome	6.57e-07	8.66e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—KDR—epilepsy syndrome	6.52e-07	8.6e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—KDR—epilepsy syndrome	6.52e-07	8.6e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—epilepsy syndrome	6.52e-07	8.59e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—epilepsy syndrome	6.52e-07	8.59e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PRKCB—epilepsy syndrome	6.49e-07	8.56e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—AKT1—epilepsy syndrome	6.48e-07	8.55e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6ST—epilepsy syndrome	6.47e-07	8.53e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—epilepsy syndrome	6.45e-07	8.5e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.42e-07	8.46e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.39e-07	8.43e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AGT—epilepsy syndrome	6.37e-07	8.4e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—JUN—epilepsy syndrome	6.36e-07	8.39e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—JUN—epilepsy syndrome	6.36e-07	8.39e-06	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—AKT1—epilepsy syndrome	6.3e-07	8.3e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PRKCB—epilepsy syndrome	6.28e-07	8.28e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PRKCB—epilepsy syndrome	6.28e-07	8.28e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6ST—epilepsy syndrome	6.25e-07	8.25e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6ST—epilepsy syndrome	6.25e-07	8.25e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—APOE—epilepsy syndrome	6.24e-07	8.23e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—epilepsy syndrome	6.24e-07	8.23e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—epilepsy syndrome	6.24e-07	8.23e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—SRC—epilepsy syndrome	6.16e-07	8.13e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—POMC—epilepsy syndrome	6.15e-07	8.11e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	6.1e-07	8.04e-06	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—AKT1—epilepsy syndrome	6.09e-07	8.03e-06	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—AKT1—epilepsy syndrome	6.09e-07	8.03e-06	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—AKT1—epilepsy syndrome	6.04e-07	7.97e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	6.03e-07	7.95e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—TH—epilepsy syndrome	6.01e-07	7.92e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VEGFA—epilepsy syndrome	6e-07	7.92e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AGT—epilepsy syndrome	6e-07	7.91e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—POMC—epilepsy syndrome	5.91e-07	7.8e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—SRC—epilepsy syndrome	5.9e-07	7.78e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—APOE—epilepsy syndrome	5.88e-07	7.75e-06	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—AKT1—epilepsy syndrome	5.85e-07	7.71e-06	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—AKT1—epilepsy syndrome	5.85e-07	7.71e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—epilepsy syndrome	5.8e-07	7.64e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCL2—epilepsy syndrome	5.79e-07	7.63e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—POMC—epilepsy syndrome	5.72e-07	7.54e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—POMC—epilepsy syndrome	5.72e-07	7.54e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—SRC—epilepsy syndrome	5.71e-07	7.53e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—SRC—epilepsy syndrome	5.71e-07	7.53e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—epilepsy syndrome	5.64e-07	7.44e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—epilepsy syndrome	5.61e-07	7.4e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCL2—epilepsy syndrome	5.6e-07	7.38e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCL2—epilepsy syndrome	5.6e-07	7.38e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—epilepsy syndrome	5.46e-07	7.2e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—epilepsy syndrome	5.46e-07	7.2e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—SRC—epilepsy syndrome	5.45e-07	7.18e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—POMC—epilepsy syndrome	5.36e-07	7.07e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—SRC—epilepsy syndrome	5.27e-07	6.95e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—SRC—epilepsy syndrome	5.27e-07	6.95e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—FGF2—epilepsy syndrome	5.23e-07	6.9e-06	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—AKT1—epilepsy syndrome	5.17e-07	6.81e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—FGF2—epilepsy syndrome	5.06e-07	6.67e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—FGF2—epilepsy syndrome	5.06e-07	6.67e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.05e-07	6.66e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	5.01e-07	6.61e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.95e-07	6.52e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	4.91e-07	6.47e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—epilepsy syndrome	4.89e-07	6.44e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RELA—epilepsy syndrome	4.85e-07	6.4e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.81e-07	6.35e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MTOR—epilepsy syndrome	4.76e-07	6.28e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RELA—epilepsy syndrome	4.7e-07	6.19e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RELA—epilepsy syndrome	4.7e-07	6.19e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MTOR—epilepsy syndrome	4.6e-07	6.07e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MTOR—epilepsy syndrome	4.6e-07	6.07e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—epilepsy syndrome	4.6e-07	6.07e-06	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—AKT1—epilepsy syndrome	4.53e-07	5.98e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.47e-07	5.9e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CASP3—epilepsy syndrome	4.38e-07	5.77e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.27e-07	5.64e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—JUN—epilepsy syndrome	4.25e-07	5.61e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CASP3—epilepsy syndrome	4.24e-07	5.59e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CASP3—epilepsy syndrome	4.24e-07	5.59e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—epilepsy syndrome	4.14e-07	5.46e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—JUN—epilepsy syndrome	4.11e-07	5.43e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—JUN—epilepsy syndrome	4.11e-07	5.43e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.03e-07	5.31e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—AKT1—epilepsy syndrome	4.01e-07	5.29e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—epilepsy syndrome	4e-07	5.28e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—epilepsy syndrome	4e-07	5.28e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.92e-07	5.17e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—AKT1—epilepsy syndrome	3.88e-07	5.12e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—AKT1—epilepsy syndrome	3.88e-07	5.12e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.84e-07	5.07e-06	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—AKT1—epilepsy syndrome	3.83e-07	5.05e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—SRC—epilepsy syndrome	3.81e-07	5.03e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—epilepsy syndrome	3.72e-07	4.9e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—SRC—epilepsy syndrome	3.69e-07	4.87e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—SRC—epilepsy syndrome	3.69e-07	4.87e-06	CbGpPWpGaD
Loperamide—CALM3—Immune System—AKT1—epilepsy syndrome	3.67e-07	4.84e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—epilepsy syndrome	3.59e-07	4.74e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—epilepsy syndrome	3.59e-07	4.74e-06	CbGpPWpGaD
Loperamide—CALM2—Immune System—AKT1—epilepsy syndrome	3.55e-07	4.68e-06	CbGpPWpGaD
Loperamide—CALM1—Immune System—AKT1—epilepsy syndrome	3.55e-07	4.68e-06	CbGpPWpGaD
Loperamide—CALM3—Disease—AKT1—epilepsy syndrome	3.39e-07	4.46e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.3e-07	4.35e-06	CbGpPWpGaD
Loperamide—CALM1—Disease—AKT1—epilepsy syndrome	3.27e-07	4.32e-06	CbGpPWpGaD
Loperamide—CALM2—Disease—AKT1—epilepsy syndrome	3.27e-07	4.32e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.01e-07	3.97e-06	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—AKT1—epilepsy syndrome	2.91e-07	3.84e-06	CbGpPWpGaD
Loperamide—CALM3—Metabolism—AKT1—epilepsy syndrome	2.84e-07	3.74e-06	CbGpPWpGaD
Loperamide—CALM1—Metabolism—AKT1—epilepsy syndrome	2.74e-07	3.62e-06	CbGpPWpGaD
Loperamide—CALM2—Metabolism—AKT1—epilepsy syndrome	2.74e-07	3.62e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.63e-07	3.47e-06	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—AKT1—epilepsy syndrome	2.47e-07	3.25e-06	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—AKT1—epilepsy syndrome	2.37e-07	3.13e-06	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—AKT1—epilepsy syndrome	2.29e-07	3.02e-06	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—AKT1—epilepsy syndrome	2.29e-07	3.02e-06	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.15e-07	2.83e-06	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.02e-07	2.67e-06	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.32e-07	1.75e-06	CbGpPWpGaD
